 Diabetes Mellitus, Experimental
"Diabetes Mellitus, Experimental" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.
| Descriptor ID |
D003921
|
| MeSH Number(s) |
C18.452.394.750.074 C19.246.240 E05.598.500.374
|
| Concept/Terms |
Streptozotocin Diabetes- Streptozotocin Diabetes
- Diabetes, Streptozotocin
- Streptozocin Diabetes
- Diabete, Streptozocin
- Diabetes, Streptozocin
- Streptozocin Diabete
|
Below are MeSH descriptors whose meaning is more general than "Diabetes Mellitus, Experimental".
Below are MeSH descriptors whose meaning is more specific than "Diabetes Mellitus, Experimental".
This graph shows the total number of publications written about "Diabetes Mellitus, Experimental" by people in this website by year, and whether "Diabetes Mellitus, Experimental" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 0 | 1 | 1 | | 2000 | 0 | 1 | 1 | | 2001 | 1 | 0 | 1 | | 2002 | 2 | 2 | 4 | | 2003 | 1 | 1 | 2 | | 2004 | 1 | 1 | 2 | | 2005 | 3 | 2 | 5 | | 2006 | 4 | 2 | 6 | | 2007 | 1 | 0 | 1 | | 2008 | 3 | 2 | 5 | | 2009 | 1 | 0 | 1 | | 2010 | 3 | 0 | 3 | | 2011 | 3 | 1 | 4 | | 2012 | 2 | 1 | 3 | | 2013 | 3 | 1 | 4 | | 2014 | 3 | 1 | 4 | | 2015 | 4 | 2 | 6 | | 2016 | 4 | 0 | 4 | | 2017 | 3 | 2 | 5 | | 2018 | 3 | 3 | 6 | | 2019 | 4 | 2 | 6 | | 2020 | 4 | 1 | 5 | | 2021 | 0 | 5 | 5 | | 2022 | 2 | 0 | 2 | | 2023 | 5 | 0 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Diabetes Mellitus, Experimental" by people in Profiles.
-
Kalahasti KK, Kumar CU, Nagaraju M, Petrash JM, Reddy SS, Reddy GB. Mitigation of lens opacification by a functional food in a diabetic rodent model. Chem Biol Interact. 2024 Feb 25; 390:110889.
-
Peddibhotla S, Caples K, Mehta A, Chen QY, Hu J, Idlett-Ali S, Zhang L, Zgheib C, Xu J, Liechty KW, Malany S. Triazolothiadiazine derivative positively modulates CXCR4 signaling and improves diabetic wound healing. Biochem Pharmacol. 2023 10; 216:115764.
-
Zhang J, Sharma D, Dinabandhu A, Sanchez J, Applewhite B, Jee K, Deshpande M, Flores-Bellver M, Hu MW, Guo C, Salman S, Hwang Y, Anders NM, Rudek MA, Qian J, Canto-Soler MV, Semenza GL, Montaner S, Sodhi A. Targeting hypoxia-inducible factors with 32-134D safely and effectively treats diabetic eye disease in mice. J Clin Invest. 2023 07 03; 133(13).
-
Akbari MS, Keogh RA, Radin JN, Sanchez-Rosario Y, Johnson MDL, Horswill AR, Kehl-Fie TE, Burcham LR, Doran KS. The impact of nutritional immunity on Group B streptococcal pathogenesis during wound infection. mBio. 2023 08 31; 14(4):e0030423.
-
Cheng HS, P?rez-Cremades D, Zhuang R, Jamaiyar A, Wu W, Chen J, Tzani A, Stone L, Plutzky J, Ryan TE, Goodney PP, Creager MA, Sabatine MS, Bonaca MP, Feinberg MW. Impaired angiogenesis in diabetic critical limb ischemia is mediated by a miR-130b/INHBA signaling axis. JCI Insight. 2023 05 22; 8(10).
-
Cheng HS, Zhuang R, P?rez-Cremades D, Chen J, Jamaiyar A, Wu W, Sausen G, Tzani A, Plutzky J, Henao-Mejia J, Goodney PP, Creager MA, Sabatine MS, Bonaca MP, Feinberg MW. A miRNA/CXCR4 signaling axis impairs monopoiesis and angiogenesis in diabetic critical limb ischemia. JCI Insight. 2023 04 10; 8(7).
-
Arble DM, Hutch CR, Hafner H, Stelmak D, Leix K, Sorrell J, Pressler JW, Gregg B, Sandoval DA. The role of preproglucagon peptides in regulating ?-cell morphology and responses to streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab. 2023 03 01; 324(3):E217-E225.
-
Li W, Zhang Y, Li R, Wang Y, Chen L, Dai S. A Novel Tolerogenic Antibody Targeting Disulfide-Modified Autoantigen Effectively Prevents Type 1 Diabetes in NOD Mice. Front Immunol. 2022; 13:877022.
-
Iheagwam FN, Iheagwam OT, Onuoha MK, Ogunlana OO, Chinedu SN. Terminalia catappa aqueous leaf extract reverses insulin resistance, improves glucose transport and activates PI3K/AKT signalling in high fat/streptozotocin-induced diabetic rats. Sci Rep. 2022 06 23; 12(1):10711.
-
Li K, Ji X, Seeley R, Lee WC, Shi Y, Song F, Liao X, Song C, Huang X, Rux D, Cao J, Luo X, Anderson SM, Huang W, Long F. Impaired glucose metabolism underlies articular cartilage degeneration in osteoarthritis. FASEB J. 2022 06; 36(6):e22377.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|